Astellas US Holding, Inc. v. Federal Insurance Company

Track this case

Case overview

Case Number:

21-3075

Court:

Appellate - 7th Circuit

Nature of Suit:

4110 Insurance

Companies

Sectors & Industries:

  1. August 15, 2023

    7th Circ. Refuses To Revisit $10M Drug Co. Coverage Ruling

    The Seventh Circuit rejected a Chubb unit's request for the court to reconsider whether the insurer should cover $10 million of a $100 million settlement reached between drugmaker Astellas and the U.S. Department of Justice.

  2. June 27, 2023

    Biggest Specialty Lines Cases From The 1st Half Of 2023

    The first half of 2023 brought a blockbuster reversal for Towers Watson's insurers regarding a so-called bump-up exclusion's applicability, along with a policyholder win in Delaware that could shake up directors and officers coverage for special purpose acquisition companies and yet another Merck win in its long-running cyber coverage dispute. Here, Law360's Insurance Authority breaks down the most important specialty lines rulings so far this year.

  3. May 03, 2023

    Chubb Unit Owes $10M For Drug Co.'s Deal, 7th Circ. Affirms

    A Seventh Circuit panel on Wednesday affirmed an Illinois federal court's ruling that a Chubb unit is responsible for paying $10 million to Astellas to cover the drugmaker's $100 million settlement with the U.S. Department of Justice over alleged Medicare fraud.

  4. January 02, 2023

    D&O Insurance Cases To Watch In 2023

    Federal appellate courts across the country are poised to weigh in on some of the thorniest issues in directors and officers coverage over the course of 2023, with opinions expected on whether government investigations count as securities claims, the so-called bump-up exclusion and a key False Claims Act dispute. Here, Law360 breaks down the top D&O insurance cases to watch this year.

  5. September 09, 2022

    Drugmaker Kickback Deal Isn't A Covered Loss, 7th Circ. Told

    A Chubb unit told the Seventh Circuit Friday that it should not have to pay drugmaker Astellas $10 million toward a settlement with the U.S. Department of Justice to resolve an investigation into possible Medicare fraud, arguing that insuring what the company paid back for an intentional kickback scheme would only incentivize such misconduct.

  6. May 12, 2022

    Astellas Tells 7th Circ. Insurer Can't Skirt DOJ Deal Coverage

    Drugmaker Astellas told the Seventh Circuit that a Chubb unit must cover part of its $100 million settlement with the U.S. Department of Justice over an alleged Medicare fraud scheme, saying the deal was not uninsurable disgorgement or restitution.

  7. March 10, 2022

    Insurer Tells 7th Circ. It Can't Cover Astellas' DOJ Settlement

    A Chubb unit told the Seventh Circuit it shouldn't have to cover part of drugmaker Astellas' $100 million settlement with the U.S. Department of Justice over an alleged Medicare fraud scheme because the payment amounted to restitution, which the insurer says is barred under its policy and Illinois law.